All Articles

Warfarin may cut cancer risk

Research suggests warfarin may have anti-cancer potential. Could this have implications for anticoagulation patients?

Tremfya launched for psoriasis

Janssen has launched guselkumab (Tremfya) for adults with moderate to severe plaque psoriasis

Quadrivalent flu jab launched

Sanofi Pasteur recently launched a quadrivalent influenza vaccine in the UK that protects against two A and two B strains

New antibiotic launched

Pfizer has launched Zavicefta (ceftazidime-avibactam) for adults hospitalised with serious infections

Verapamil for rhinosinusitis?

Verapamil dramatically improves symptom scores in patients with chronic rhinosinusitis and nasal polyps

NSAIDs and paracetamol linked to hearing loss

NSAIDs and paracetamol might increase the risk of hearing loss, according to an analysis of 55,850 women

Rotavirus vaccine is preventing gastroenteritis in infants

Infant rotavirus vaccine reduces the number of episodes of acute gastroenteritis by up to half and saves £12.5m a year

Teva launches reformulated levothyroxine range

Teva has launched a reformulated version of levothyroxine, including two previously unavailable strengths

Xultophy approved for renal impairment

Xultophy has been approved for adults with type 2 diabetes and moderate renal impairment

Update: media scare stories cutting statin use?

Media stories questioning the safety of statins are causing people to stop taking the drugs

Update: Enstilar – new psoriasis drug

Enstilar (calcipotriol and betamethasone dipropionate) is a new topical, alcohol-free, foam spray for plaque psoriasis

Massive increase in ADHD prescribing

Prescriptions for ADHD drugs in the UK increased by almost 800 per cent between 2000 and 2015

Benzodiazepines could significantly increase flu risk

Benzodiazepines may increase mortality more than 20-fold in people with influenza-like illness, new research finds

Actavis adds gliclazide 40mg

Actavis has added gliclazide 40mg tablets alongside the existing 80mg tablet offer

New ticagrelor dose

Marketing authorisation has been granted for a 60mg dose of ticagrelor for patients who have suffered a heart attack  

New lung cancer drug

The European Commission has granted marketing authorisation for necitumumab (Portrazza) for lung cancer

Ezetimibe indication widened

The MHRA recently extended the indication for ezetimibe (Ezetrol)

Dementia script numbers rise but costs fall

The number of prescriptions for drugs for Alzheimer’s disease rose more than six-fold over the past decade

GORD quality standards

NICE has published nine quality standards covering GORD in children and young people

Cyramza’s new cancer indications

The European Commission recently approved two new indications for ramucirumab (Cyramza)
Previous 1 2 3 4 Next

Latest

RPS: a “scandal” not to make best use of pharmacists

The RPS’s Sandra Gidley has said it would be “nothing short of a scandal” if health services did not make best use...

Survey: Tell us your views about pharmacy in 2018

Pharmacy Magazine is updating our 2017 research looking at the key issues affecting the sector – and we want to hear y...

Views

Workload pressures are a sector-wide issue and need to be address…

By Richard Thomas, editor, Pharmacy Magazine. I spent an hour recently in a dispensary waiting to interview the pharmaci...

Popular

GPhC welcomes positive PSA review

The GPhC has met all of the Professional Standards Authority’s standards for good regulation in 2016/17

NHS England will not respond to Murray review

NHS England will not publish a response to the Murray review of community pharmacy clinical services, APPG meeting told

Winter ailments: Help cut the queues

Winter provides the perfect opportunity for pharmacy to ease the pressure on GP surgeries and A&E departments